Gene · 9476
NAPSA: napsin A aspartic peptidase
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NAPSA: napsin A aspartic peptidase. Genes, record 9476. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9476
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O96009 | Napsin-A | 420 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents60
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 1465 | O96009 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1080 | O96009 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 9174 | O96009 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 1897 | O96009 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7115 | O96009 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7115 | O96009 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1080 | O96009 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1465 | O96009 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 9174 | O96009 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 9174 | O96009 | Espacenet |
1 to 10 of 60
See all 60 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants618
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NAPSA papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 39 | 2025 |
| R01HL095993 | Derivation of lung epithelia from iPS cells for advanced disease modeling | 10 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 8 | 2025 |
| P30ES013508 | Center of Excellence in Environmental Toxicology | 4 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 4 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 4 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 3 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 3 | 2025 |
| P30CA071789 | University of Hawaii Cancer Center CCSG | 3 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 618Source NIH's project files
See all 618 nih grantsPapers2,888
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Small-Bowel Perforation Caused by Multiple Metastases from Lung Adenocarcinoma Preceded by Obscure Gastrointestinal Bleeding: A Case Report. | Surg Case Rep | 2026 | 42787081 | PubTator, text mining | PubMed |
| Case Report: Invasive mucinous adenocarcinoma mimicking interstitial pneumonia with autoimmune features: diagnostic pitfalls and reflections. | Front Immunol | 2026 | 42774218 | PubTator, text mining | PubMed |
| [A Case of Stage Ⅳ Lung Adenocarcinoma with Bilateral Breast Metastases Mimicking Inflammatory Breast Cancer]. | Gan To Kagaku Ryoho | 2026 | 42750623 | PubTator, text mining | PubMed |
| Combining Napsin A expression with circulating tumor cell counts for enhanced identification of pulmonary adenocarcinoma in ground-glass nodules. | Transl Cancer Res | 2026 | 42724459 | PubTator, text mining | PubMed |
| Case Report: Synchronous SCLC and minimally invasive adenocarcinoma in the same lobe: NGS-confirmed cross-histological molecular heterogeneity in an ultra-rare case. | Front Oncol | 2026 | 42723765 | PubTator, text mining | PubMed |
| Staged traditional Chinese medicine treatment for suspected pulmonary inflammatory pseudotumor with progressive lesion reduction: a case report and literature review. | Front Med (Lausanne) | 2026 | 42694241 | PubTator, text mining | PubMed |
| Case Report: Hidden danger in breast eczematous lesions: cutaneous metastasis from silent lung adenocarcinoma misdiagnosed as Paget's disease. | Front Oncol | 2026 | 42688082 | PubTator, text mining | PubMed |
| Case Report: Synchronous ALK-positive laryngeal inflammatory myofibroblastic tumor and EGFR-mutant lung adenocarcinoma in a child. | Front Pediatr | 2026 | 42625736 | PubTator, text mining | PubMed |
| An Unusual Low-Grade Biphasic Pulmonary Neoplasm Harboring BRAF-V600E Mutation: A Potential Variant of Bronchiolar Adenoma. | Int J Surg Pathol | 2026 | 42595357 | PubTator, text mining | PubMed |
| ALK-rearranged lung adenocarcinoma transforming to mucoepidermoid carcinoma in a 45-year-old female: a case report. | AME Case Rep | 2026 | 42592384 | PubTator, text mining | PubMed |
1 to 10 of 2,888
See all 2,888 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9476
GET https://conductscience.org/api/genes/v1/9476/patents?page=2